Aspirin-triggered lipoxin A4 reduces inflammation in microglial cells
Author Information
Author(s): Wang Yan-Ping, Wu Yan, Li Long-Yan, Zheng Jin, Liu Ren-Gang, Zhou Jie-Ping, Yuan Shi-Ying, Shang You, Yao Shang-Long
Primary Institution: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Hypothesis
Does aspirin-triggered lipoxin A4 (ATL) inhibit pro-inflammatory responses in microglial cells activated by lipopolysaccharide (LPS)?
Conclusion
ATL inhibits the production of nitric oxide and pro-inflammatory cytokines in microglial cells, suggesting its potential as a therapeutic agent for neurodegenerative diseases.
Supporting Evidence
- ATL significantly reduced the production of nitric oxide, IL-1β, and TNF-α in a concentration-dependent manner.
- ATL inhibited the nuclear translocation of NF-κB and the degradation of IκB-α.
- ATL's effects were reversed by Boc-2, indicating a receptor-mediated mechanism.
Takeaway
This study shows that a substance called ATL can help calm down angry brain cells that cause inflammation, which might help with brain diseases.
Methodology
BV-2 microglial cells were treated with ATL before exposure to LPS, and various inflammatory markers were measured using assays like ELISA and PCR.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website